(195) - CD38-Antibody Daratumumab in Allosensitized Recipients for Heart Transplantation: Outcomes and 3-Years of Single-Centre Experience

Autor: Moayedifar, R., Koren, D., Fischer, G., Nackenhorst, M., Uyanik-Uenal, K., Goekler, J., Boehmig, G., Aliabadi-Zuckermann, A., Zuckermann, A.
Zdroj: In Journal of Heart and Lung Transplantation April 2024 43(4) Supplement:S103-S103
Databáze: ScienceDirect